Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers (Q35881722)

10 August 2017

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers (English)

1 reference

10 August 2017

0 references

4

Robert Sebra

1 reference

10 August 2017

15

Eric Schadt

1 reference

10 August 2017

Elena Pereira

1

1 reference

10 August 2017

Olga Camacho-Vanegas

2

1 reference

10 August 2017

Sanya Anand

3

1 reference

10 August 2017

Sandra Catalina Camacho

5

1 reference

10 August 2017

Leopold Garnar-Wortzel

6

1 reference

10 August 2017

Navya Nair

7

1 reference

10 August 2017

Erin Moshier

8

1 reference

10 August 2017

Melissa Wooten

9

1 reference

10 August 2017

Andrew Uzilov

10

1 reference

10 August 2017

Rong Chen

11

1 reference

10 August 2017

Monica Prasad-Hayes

12

1 reference

10 August 2017

Konstantin Zakashansky

13

1 reference

10 August 2017

Ann Marie Beddoe

14

1 reference

10 August 2017

Peter Dottino

16

1 reference

10 August 2017

John A Martignetti

17

1 reference

10 August 2017

language of work or name

English

0 references

publication date

30 December 2015

1 reference

10 August 2017

1 reference

10 August 2017

10

1 reference

10 August 2017

e0145754

1 reference

10 August 2017

12

1 reference

Creative Commons Attribution 4.0 International

10 August 2017

start time

30 December 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Monitoring gastric cancer progression with circulating tumour DNA.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Which imaging technique should we use in the follow up of gynaecological cancer?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Detection of circulating tumor DNA in early- and late-stage human malignancies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Analysis of circulating tumor DNA to monitor metastatic breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Effect of Screening on Ovarian Cancer Mortality

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Role of tumour markers in monitoring epithelial ovarian cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26717006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26717006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26717006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0145754

1 reference

10 August 2017

0 references

1 reference

10 August 2017

1 reference